UCB’s VimpatŪ Approved By U.S. FDA As Adjunctive Therapy For Partial Onset Seizures In Adults
Oct 29th 2008Drug InformationEpilepsy
UCB announced today that the U.S. Food and Drug Administration (FDA) has approved VimpatŪ (lacosamide), a new antiepileptic drug (AED). VimpatŪ is for use as an add-on therapy for the treatment of partial-onset seizures in people with epilepsy who are 17 years and older. “Having a new antiepileptic drug option may offer adults with partial onset seizures the chance to obtain seizure control.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
